Shares of Moderna Inc. MRNA dropped 0.31% to $63.94 Tuesday, on what proved to be an all-around favorable trading session for ...

Moderna (MRNA) closed at $63.94 in the latest trading session, marking a -0.31% move from the prior day. This change lagged the S&P 500's 0.25% gain on the day. At the same time, the Dow added 0.2%, ...

Moderna 's ( MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Shares of Moderna Inc. MRNA shed 2.36% to $64.14 Monday, on what proved to be an all-around positive trading session for the ...